Monogram Technologies Inc

Monogram Technologies Inc(MGRM)股票分析

$6.000

-0.108 (-1.80%)收盤時

Loading chart…
High
6.425
Open
6.100
VWAP
6.10
Vol
1.78M
Mkt Cap
65.56M
Low
5.870
Amount
10.84M
EV/EBITDA, TTM
-3.28

Monogram Technologies Inc. is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining 3D printing, advanced machine vision, AI and robotics. The Company's mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its FDA-cleared mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. It is also exploring other clinical and commercial applications for mBos with mVision navigation. Its mVision technology leverages AI-trained algorithms to track pre-identified objects in real-time.

估值指標

The current forward P/E ratio for Monogram Technologies Inc (MGRM) is -3.30, compared to its 5-year average forward P/E of -5.34.

Forward P/E

Fair
5Y Average P/E
-5.34
Current P/E
-3.30
高估
0.02
低估
-10.70

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-5.46
Current EV/EBITDA
-3.28
高估
1.03
低估
-11.95

Forward P/S

Fair
5Y Average P/S
24.22
Current P/S
14.06
高估
57.45
低估
-9.00

Alphio AI Price Scenarios for MGRM

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%MGRM

$6.90

情境價格

B

Base

Base · 50%MGRM

$6.18

情境價格

B

Bear

Bear · 25%MGRM

$5.93

情境價格

事件時間軸

2025-10-07 (ET)

09:06:58

Zimmer Biomet finalizes purchase of Monogram Technologies

2025-07-29 (ET)

09:34:04

Monogram completes fully autonomous saw-based robotic knee replacement procedure

2025-07-14 (ET)

07:39:29

Zimmer Biomet to acquire Monogram for $4.04 per share in cash upfront

07:32:34

Zimmer Biomet to acquire Monogram Orthopaedics for $177M

2025-07-08 (ET)

08:53:14

Monogram Orthopaedics announces conversion of Series D Preferred Stock

資訊

MGRM FAQ — answered by Alphio AI

Monogram Technologies Inc. is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining 3D printing, advanced machine vision, AI and robotics. The Company's mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its FDA-cleared mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. It is also exploring other clinical and commercial applications for mBos with mVision navigation. Its mVision technology leverages AI-trained algorithms to track pre-identified objects in real-time. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始